R2H
In Practice

Days of literature review.
Minutes with Clarisyn.

A real compound. A real question. A real answer.

The Scenario

The Question

"Predict the metabolic fate of the following compound (CAS No. 84057-84-1; SMILES: C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N), a triazine-based scaffold bearing a 2,3-dichlorophenyl group and an aminopyrazole moiety. Focus on CYP-mediated bioactivation pathways, potential reactive intermediate formation, and implications for genotoxicity or covalent protein adduction. Recommend mechanistic follow-up studies to characterise the risk."

Analysis Type

Quick Analysis

Duration

30 minutes

Layer 1· Intelligence Report

Key takeaways first, then a full structured synthesis of the literature. Multiple agents, multiple angles, one clear answer.

Intelligence Report Page 1
Image: /intelligence-blur-1.png
Intelligence Report Page 2
Image: /intelligence-blur-2.png

Layer 2· Reasoning & Process

Every scoring and decision step, logged for full transparency. The complete reasoning trail behind every finding.

Reasoning Page 1
Image: /reasoning-blur-1.png
Reasoning Page 2
Image: /reasoning-blur-2.png

Layer 3· Evidence & Sources

49 curated sources across 200+ preclinical and clinical datasets. Every claim traceable to its origin.

Evidence Page 1
Image: /reference-blur-1.png
Evidence Page 2
Image: /reference-blur-2.png
"Clarisyn turns days of literature review into minutes, delivering a structured, reliable report that is immediately usable. Where deeper expert interpretation is needed, a built-in consultation pathway transforms it from a starting point into a genuine collaborative tool."

Prof. Alan Boobis, OBE

Emeritus Professor of Toxicology, Imperial College London.
Former Chair, UK Committee on Toxicity.